CIBC Asset Management Inc Sells 228 Shares of Teleflex Incorporated (NYSE:TFX)

CIBC Asset Management Inc lessened its holdings in Teleflex Incorporated (NYSE:TFX) by 3.3% during the 4th quarter, HoldingsChannel reports. The firm owned 6,638 shares of the medical technology company’s stock after selling 228 shares during the period. CIBC Asset Management Inc’s holdings in Teleflex were worth $1,181,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Janus Henderson Group PLC increased its position in Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after purchasing an additional 147,147 shares during the last quarter. State Street Corp boosted its stake in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after buying an additional 21,291 shares during the period. Geode Capital Management LLC boosted its stake in Teleflex by 0.5% during the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after buying an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Teleflex by 0.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after buying an additional 1,884 shares during the period. Finally, Point72 Asset Management L.P. boosted its stake in Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after buying an additional 96,958 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 0.2 %

Shares of TFX opened at $175.43 on Friday. The firm has a market capitalization of $8.15 billion, a P/E ratio of 34.88, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $165.62 and a 12-month high of $249.90. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a fifty day moving average price of $176.98 and a 200-day moving average price of $207.40.

Wall Street Analysts Forecast Growth

TFX has been the subject of several recent analyst reports. Royal Bank of Canada dropped their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Truist Financial lowered their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.